| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.28B | +20.9% |
| Cost of Revenue | $2.98B | +30.4% |
| Gross Profit | $10.29B | +18.4% |
| R&D Expense | $2.96B | +16.4% |
| SG&A Expense | $1.12B | +20.0% |
| Operating Income | $1.82B | +33.7% |
| Pre-tax Income | $2.26B | +30.1% |
| Income Tax | $513.0M | +63.9% |
| Net Income | $1.75B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.73B | +61.7% |
| Accounts Receivable | $2.63B | +17.3% |
| Current Assets | $10.47B | +14.0% |
| Total Assets | $26.04B | +27.7% |
| Current Liabilities | $10.44B | +24.9% |
| Total Liabilities | $13.07B | +21.3% |
| Stockholders' Equity | $12.96B | +34.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.44B | +27.6% |
| Capital Expenditures | $868.0M | +1.9% |
| Investing Cash Flow | -$1.69B | +32.5% |
| Financing Cash Flow | -$2.34B | -74.2% |
| Free Cash Flow | $4.58B | +34.0% |
| +22.7% |
| EPS (Basic) | $1.69 | -75.6% |
| EPS (Diluted) | $1.67 | -75.6% |